The Indian pharma industry is confident of achieving exports of $25 billion by 2014 at an annual growth rate of 25 per cent.
Last year, the industry registered exports of $13 billion at a growth rate of 30 per cent, Dr P.V. Appaji, Director-General of Pharmexil, said.
The industry expects to get at least $10 billion worth of export opportunity when drugs worth $35 billion go off patent in the US.